Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Carcinoma, Transitional Cell × enfortumab vedotin × Clear all

Phase

Phase 2 8 Phase 1 6 Phase 1/2 5 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 1

Interventions

Gemcitabine 4 Cisplatin 2 vinflunine 1 valrubicin 1 pembrolizumab 1 enfortumab vedotin 1 cabazitaxel 1 XRP6258 1 Rogaratinib 1 Oncolytic Virotherapy 1 Mitomycin 1 Interferons 1 Drug Therapy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06493552 2025-04-03

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Vasgene Therapeutics, Inc

Phase 2/3 Recruiting

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡